Lucie Klimešová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lucie Klimešová has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Eva Benešová
Department of Biochemistry and Microbiology University of Chemistry and Technology Prague Czech Republic
1 shared publication - Helena Pelantová
Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic
1 shared publication - Lucie Petrásková
Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, CZ 142 00, Czech Republic
1 shared publication - Patricie Vodickova
Department of Biochemistry and Microbiology University of Chemistry and Technology Prague Czech Republic
1 shared publication - Pavla Bojarová
Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic
1 shared publication - Pavlína Nekvasilová
Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic
1 shared publication
Latest Publications
- Open Access
- 23 April 2026
- Published by Wiley in Microbial Biotechnology
- Vol. 19 (4) , e70354
Transglycosylation Capabilities of Wild‐Type α‐ l ‐Fucosidase iso1 from Paenibacillus thiaminolyticus and Its Engineered Mutants: Preparation of Fucosylated Oligosaccharides
To enhance the yield of l ‐fucosylated molecules synthesized via transfucosylation, we employed α‐ l ‐transfucosidases, enzymes engineered from α‐ l ‐fucosidases to favour transglycosylation over hydrolysis. This study investigated the transglycosylation potential of mutated variants of α‐ l ‐fucosidase iso1 from Paenibacillus thiaminolyticus designed by structural comparison with Thermotoga maritima α‐ l ‐transfucosidase. Using site‐directed mutagenesis, point mutations (S237A, S237G, S237P, S237V, Y189F) were introduced, and the corresponding recombinant proteins were successfully expressed and purified. Among them, the S237V variant achieved the highest overall yield of fucosylated lactose and increased the transglycosylation/hydrolysis ratio more than 20‐fold compared to the wild‐type enzyme. This variant enabled regioselective synthesis of 3′‐and 6′‐fucosyllactose, as well as a functionalized 3′‐fucosyllactose bearing a Boc‐protected ethylthioureidyl linker (3′‐FucLac‐ t Boc), with all structures confirmed by NMR spectroscopy. The engineered α‐ l ‐transfucosidase iso1 from Paenibacillus thiaminolyticus catalysed the regioselective synthesis of structurally defined fucosyllactose derivatives, including C‐1 functionalized analogs suitable for immobilization on biosensor surfaces or macromolecular scaffolds, thus expanding the biocatalytic toolbox and demonstrating the potential of semi‐rational enzyme design for targeted HMO‐based glycoengineering applications.
- 23 April 2026
- Published by Wiley in Microbial Biotechnology
- Vol. 19 (4) , e70354
Open AccessTransglycosylation Capabilities of Wild‐Type α‐ l ‐Fucosidase iso1 from Paenibacillus thiaminolyticus and Its Engineered Mutants: Preparation of Fucosylated Oligosaccharides
To enhance the yield of l ‐fucosylated molecules synthesized via transfucosylation, we employed α‐ l ‐transfucosidases, enzymes engineered from α‐ l ‐fucosidases to favour transglycosylation over hydrolysis. This study investigated the transglycosylation potential of mutated variants of α‐ l ‐fucosidase iso1 from Paenibacillus thiaminolyticus designed by structural comparison with Thermotoga maritima α‐ l ‐transfucosidase. Using site‐directed mutagenesis, point mutations (S237A, S237G, S237P, S237V, Y189F) were introduced, and the corresponding recombinant proteins were successfully expressed and purified. Among them, the S237V variant achieved the highest overall yield of fucosylated lactose and increased the transglycosylation/hydrolysis ratio more than 20‐fold compared to the wild‐type enzyme. This variant enabled regioselective synthesis of 3′‐and 6′‐fucosyllactose, as well as a functionalized 3′‐fucosyllactose bearing a Boc‐protected ethylthioureidyl linker (3′‐FucLac‐ t Boc), with all structures confirmed by NMR spectroscopy. The engineered α‐ l ‐transfucosidase iso1 from Paenibacillus thiaminolyticus catalysed the regioselective synthesis of structurally defined fucosyllactose derivatives, including C‐1 functionalized analogs suitable for immobilization on biosensor surfaces or macromolecular scaffolds, thus expanding the biocatalytic toolbox and demonstrating the potential of semi‐rational enzyme design for targeted HMO‐based glycoengineering applications.